Skip to content
healthcare.dev
Get a free key

Lisdexamfetamine Dimesylate

NDC 0406-5129, Lisdexamfetamine Dimesylate, tablet, chewable, from SpecGx LLC.

Product NDC
0406-5129
Status
Listed
Labeler
SpecGx LLC
Dosage form
TABLET, CHEWABLE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218850
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0406-5129 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LISDEXAMFETAMINE DIMESYLATE60 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Package NDCNDC-11Package
0406-5129-0100406512901100 TABLET, CHEWABLE in 1 BOTTLE (0406-5129-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3a79b2ab-4131-4978-99a0-0119df57d5fe

  • NADAC price for package 00406512901

    GET /v1/drugs/nadac/00406512901

Use it

Look up 0406-5129 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0406-5129 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0406-5129. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.